Management

Dr. François Curtin, MD, MPhil, MBA, Chief Executive Officer

François graduated with an MD from Geneva Medical School and obtained a Master in Philosophy in Medical Statistics from the London School of Hygiene and Tropical Medicine. He has a MBA from Warwick Business School.  After several years in academia, he joined Swissmedic, the Swiss Medicine Agency where he was responsible for the registration and market surveillance of neuropsychiatric drugs. Then, he joined Serono SA, then Merck Serono SA, where he worked in clinical and business development. Since 2009, François is the CEO of GeNeuro.

Dr. Hervé Perron, HDR, Chief Scientific Officer
Hervé has a PhD in Virology and a Professoral Thesis in Neuroimmunology. He is the author of over 120 peer-reviewed publications and patents and is referee for various scientific journals. He was Research Director of R&D within bioMérieux for the development of in vitro diagnostics in the domain of Neurological diseases. Hervé was Scientific Director of bioMérieux STELHYS, a spin-off dedicated to the evaluation of developments of upstream research projects. Hervé is a co-founder and Chief Scientific Officer of GeNeuro and the general manager of GeNeuro-Innovation.

Prof. Dr. Alois B. Lang, Chief Development Officer

Alois has a PhD degree from the Swiss Federal Technology Institute of Zurich (ETHZ) and he did his postdoctoral training at the University Hospital of Zurich and with the Department of Immunology of Cetus Inc., USA. He is Professor of Immunology at the Faculty of Medicine of the University of Berne. Alois was a Head Research Immunology and Project Manager at Berna Biotech, Berne, and a co-founder and Chief Scientific Officer of an antibody biotech company. He is involved in Scientific Expert Working groups and is a regular speaker at major scientific conferences. Since 2007, he is the Chief Development Officer of GeNeuro.

Christophe Guichard, Chief Financial Officer
Christophe has been managing corporate finance activities in strong growth environments since 1994, first within KPMG/Salustro and then as the CFO of Trader Classified Media, performing major M&A transactions including two IPOs (Nasdaq / Euronext and London Stock Exchange), senior debt financings, acquisitions and divestitures. Christophe graduated from EDHEC Business School, holds the DESCF (Expertise in Finance and Accounting) and the PLD from Harvard Business School.